Northern Trust’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Northern Trust’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,160	Closed	-$51K	–	4820
2022 Q2	$51K	Sell	23,160 -2,553	-10%	-$5.1K	﹤0.01%	4410
2022 Q1	$48K	Hold	25,713	–	–	﹤0.01%	4543
2021 Q4	$56K	Hold	25,713	–	–	﹤0.01%	4576
2021 Q3	$86K	Buy	25,713 +4,839	+23%	+$13.1K	﹤0.01%	4439
2021 Q2	$56K	Hold	20,874	–	–	﹤0.01%	4476
2021 Q1	$45K	Buy	20,874 +9,081	+77%	+$25.8K	﹤0.01%	4393
2020 Q4	$29K	Hold	11,793	–	–	﹤0.01%	4295
2020 Q3	$24K	Buy	+11,793	New	+$33.6K	﹤0.01%	4193

Northern Trust's ETTX Position: Q3 2022 in Review

Northern Trust sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 23,160 shares — an estimated $51K sold.

Northern Trust first reported a position in ETTX in Q3 2020 and held it in 8 quarters. The position peaked at $86K in Q3 2021. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Northern Trust reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Northern Trust sold 23,160 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $51K.
Northern Trust first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 8 quarters.
Northern Trust's Entasis Therapeutics Holdings Inc. position peaked at $86K in Q3 2021.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.